Program Description
Gastroesophageal adenocarcinoma (GEA), encompassing stomach, gastroesophageal junction, and esophageal adenocarcinomas, is often diagnosed at an advanced stage and carries a poor prognosis. The expanding availability of targeted therapies and immunotherapies has increased the importance of biomarker testing in guiding treatment. Oncology pharmacists continue to face challenges interpreting biomarker results, applying clinical evidence to treatment selection and sequencing, and managing mechanism-specific toxicities, including interstitial lung disease and cardiotoxicity. During this live webinar, oncology pharmacists will hear from expert faculty on approaches to managing advanced GEA and practical strategies for implementation in their own settings.
Target audience: Oncology Pharmacists
Type of activity: Application
Release date: December 14, 2026
Expiration date: February 14, 2027
Time to complete activity: 1.0 hour
Learner level: Foundational, Intermediate
Fee: Free
Educational Objectives
At the completion of this activity, pharmacists will be able to:
- Apply practical biomarker testing workflows to support timely identification and clinical use of relevant biomarker results in treatment planning for advanced gastroesophageal adenocarcinoma (GEA)
- Recognize treatment strategies in advanced GEA by applying biomarker results and clinical evidence to guide appropriate selection and sequencing of targeted and immunotherapy-based regimens
- Manage therapy-related toxicities in advanced GEA with structured monitoring and supportive care strategies for targeted treatments
Allison Schepers, PharmD, BCOP
Clinical Pharmacist Specialist, Medical Oncology
University of Michigan Rogel Cancer Center
Ann Arbor, MI
Accreditation Information
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. The activity is available for CE credit through February 14, 2027.
Obtaining Credit
All participants who attended the live virtual broadcast need to log on to their Pharmacy Times Continuing Education™ account on www.pharmacytimes.org to complete an online evaluation form and request their credit. Instructions on receiving credit will be provided the day of the event.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
Allison Schepers, PharmD, BCOP, has no relevant financial relationships with ineligible companies to disclose.
Pharmacy Times Continuing Education™ Planning Staff: Jim Palatine, RPh, MBA; Rose Buszka, PharmD, BCPS, CHCP; Kylie Ferrentino; and Brianna Winters have no financial relationships with ineligible companies to disclose.
All of the relevant financial relationships listed for these individuals have been mitigated.
At least 1 anonymous peer reviewer has been used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with ineligible companies to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms